United States · FDA National Drug Code directory
KAZANO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-337_699d63c4-18d5-47a8-98d6-680cb351bbbe
- Product NDC
- 64764-337
- Form
- TABLET, FILM COATED
- Composition / generic term
- alogliptin and metformin hydrochloride
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130125
- Source listing expiry
- 20271231
Source-listed ingredients
- ALOGLIPTIN BENZOATE — 12.5 mg/1
- METFORMIN HYDROCHLORIDE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 CARTON in 1 TRAY (64764-337-01) / 1 BLISTER PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 BLISTER PACK · 64764-337-01
- 60 TABLET, FILM COATED in 1 BOTTLE (64764-337-60) · 64764-337-60
- 500 TABLET, FILM COATED in 1 BOTTLE (64764-337-77) · 64764-337-77
- 180 TABLET, FILM COATED in 1 BOTTLE (64764-337-80) · 64764-337-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →